Also known as Modified GRF (1-29) - available at 5mg, is a synthetic research peptide commonly investigated in laboratory studies involving growth hormone-related signalling pathways, receptor interaction mechanisms, and peptide stability models.
Supplied as a high-purity lyophilised peptide powder, this compound is intended strictly for controlled in-vitro research applications alongside our broader range of research peptides UK laboratories rely on. Every batch supplied by Imperial Peptides UK undergoes independent third-party analytical testing, including HPLC purity verification, identity confirmation, heavy metal screening, and endotoxin analysis. Batch-specific Certificates of Analysis (CoAs) are provided to support analytical verification, laboratory traceability, and research documentation standards.
Specifications
SKU: CND5
Form: Lyophilised peptide powder
Purity: ≥99%
Appearance: White lyophilised powder
Storage: Store at -20°C
After reconstitution: Store at 2–8°C
Chemical Information
Molecular Formula: C152H252N44O42
Molecular Weight: 3367.9 g/mol
CAS Number: 863288-34-0
→ Safety Data Sheet (SDS)
→ View Chemical Reference Data (PubChem)
Research Applications
CJC-1295 (No DAC) has been studied in a range of peptide research environments involving receptor signalling pathways, peptide interaction models, and growth hormone-related biochemical investigations. Researchers commonly utilise CJC-1295 (No DAC) in broader in-vitro studies involving peptide stability and endocrine signalling mechanisms.
⚠︎ Safety & Legal Notice
This product is supplied strictly for in-vitro laboratory research use only. It is not intended for human or veterinary use, consumption, administration, or clinical application. The purchaser is responsible for ensuring compliance with all applicable laws and regulations relating to the handling and use of research materials.